Pentwater Capital Management’s AbbVie ABBV Stock Holding History

Pentwater Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-420,000	Closed	-$31.8M	–	153
2019 Q3	$31.8M	Buy	420,000 +250,000	+147%	+$17.1M	0.5%	34
2019 Q2	$12.4M	Buy	+170,000	New	+$13.4M	0.13%	66
2015 Q3	–	Sell	-627,600	Closed	-$42.2M	–	135
2015 Q2	$42.2M	Hold	627,600	–	–	0.22%	51
2015 Q1	$36.7M	Buy	627,600 +347,600	+124%	+$21M	0.27%	50
2014 Q4	$18.3M	Sell	280,000 -966,600	-78%	-$60.9M	0.13%	67
2014 Q3	$72M	Buy	+1,246,600	New	+$69.2M	0.69%	32

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pentwater Capital Management's ABBV Position: Q1 2020 in Review

Pentwater Capital Management sold out of AbbVie (ABBV) in Q1 2020, closing a stake of 1,113 shares — an estimated $99K sold.

Pentwater Capital Management first reported a position in ABBV in Q4 2019 and held it in 1 quarter. The position peaked at $99K in Q4 2019. 2,226 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

Pentwater Capital Management reported no remaining AbbVie position as of Q1 2020 after selling out during the quarter.
Pentwater Capital Management sold 1,113 AbbVie shares in Q1 2020, an estimated $99K.
Pentwater Capital Management first reported a position in AbbVie in Q4 2019 and held it in 1 quarter.
Pentwater Capital Management's AbbVie position peaked at $99K in Q4 2019.
2,226 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on Pentwater Capital Management's 13F filing for Q1 2020, filed 15 May 2020.